142 related articles for article (PubMed ID: 26822871)
1. Polymorphisms of the FOXF1 and MHC locus genes in individuals undergoing esophageal acid reflux assessments.
Lam C; Liu WF; Bel RD; Chan K; Miller L; Brown MC; Chen Z; Cheng D; Patel D; Xu W; Darling GE; Liu G
Dis Esophagus; 2017 Feb; 30(2):1-7. PubMed ID: 26822871
[TBL] [Abstract][Full Text] [Related]
2. Barrett associated MHC and FOXF1 variants also increase esophageal carcinoma risk.
Dura P; van Veen EM; Salomon J; te Morsche RH; Roelofs HM; Kristinsson JO; Wobbes T; Witteman BJ; Tan AC; Drenth JP; Peters WH
Int J Cancer; 2013 Oct; 133(7):1751-5. PubMed ID: 23504527
[TBL] [Abstract][Full Text] [Related]
3. A newly identified susceptibility locus near FOXP1 modifies the association of gastroesophageal reflux with Barrett's esophagus.
Dai JY; de Dieu Tapsoba J; Buas MF; Onstad LE; Levine DM; Risch HA; Chow WH; Bernstein L; Ye W; Lagergren J; Bird NC; Corley DA; Shaheen NJ; Wu AH; Reid BJ; Hardie LJ; Whiteman DC; Vaughan TL
Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1739-47. PubMed ID: 26377193
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2 and inducible nitric oxide synthase gene polymorphisms and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):727-31. PubMed ID: 18349295
[TBL] [Abstract][Full Text] [Related]
5. Haplotypes of the IL-1 gene cluster are associated with gastroesophageal reflux disease and Barrett's esophagus.
Izakovicova Holla L; Borilova Linhartova P; Hrdlickova B; Marek F; Dolina J; Rihak V; Kala Z
Hum Immunol; 2013 Sep; 74(9):1161-9. PubMed ID: 23806268
[TBL] [Abstract][Full Text] [Related]
6. No association between hOGG1, XRCC1, and XPD polymorphisms and risk of reflux esophagitis, Barrett's esophagus, or esophageal adenocarcinoma: results from the factors influencing the Barrett's adenocarcinoma relationship case-control study.
Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):736-9. PubMed ID: 18349297
[TBL] [Abstract][Full Text] [Related]
7. Detailed esophageal function and morphological analysis shows high prevalence of gastroesophageal reflux disease and Barrett's esophagus in patients with cervical inlet patch.
Rosztóczy A; Izbéki F; Németh IB; Dulic S; Vadászi K; Róka R; Gecse K; Gyökeres T; Lázár G; Tiszlavicz L; Wittmann T
Dis Esophagus; 2012 Aug; 25(6):498-504. PubMed ID: 22107367
[TBL] [Abstract][Full Text] [Related]
8. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
[TBL] [Abstract][Full Text] [Related]
9. Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus.
Su Z; Gay LJ; Strange A; Palles C; Band G; Whiteman DC; Lescai F; Langford C; Nanji M; Edkins S; van der Winkel A; Levine D; Sasieni P; Bellenguez C; Howarth K; Freeman C; Trudgill N; Tucker AT; Pirinen M; Peppelenbosch MP; van der Laan LJ; Kuipers EJ; Drenth JP; Peters WH; Reynolds JV; Kelleher DP; McManus R; Grabsch H; Prenen H; Bisschops R; Krishnadath K; Siersema PD; van Baal JW; Middleton M; Petty R; Gillies R; Burch N; Bhandari P; Paterson S; Edwards C; Penman I; Vaidya K; Ang Y; Murray I; Patel P; Ye W; Mullins P; Wu AH; Bird NC; Dallal H; Shaheen NJ; Murray LJ; Koss K; Bernstein L; Romero Y; Hardie LJ; Zhang R; Winter H; Corley DA; Panter S; Risch HA; Reid BJ; Sargeant I; Gammon MD; Smart H; Dhar A; McMurtry H; Ali H; Liu G; Casson AG; Chow WH; Rutter M; Tawil A; Morris D; Nwokolo C; Isaacs P; Rodgers C; Ragunath K; MacDonald C; Haigh C; Monk D; Davies G; Wajed S; Johnston D; Gibbons M; Cullen S; Church N; Langley R; Griffin M; Alderson D; Deloukas P; Hunt SE; Gray E; Dronov S; Potter SC; Tashakkori-Ghanbaria A; Anderson M; Brooks C; Blackwell JM; Bramon E; Brown MA; Casas JP; Corvin A; Duncanson A; Markus HS; Mathew CG; Palmer CN; Plomin R; Rautanen A; Sawcer SJ; Trembath RC; Viswanathan AC; Wood N; Trynka G; Wijmenga C; Cazier JB; Atherfold P; Nicholson AM; Gellatly NL; Glancy D; Cooper SC; Cunningham D; Lind T; Hapeshi J; Ferry D; Rathbone B; Brown J; Love S; Attwood S; MacGregor S; Watson P; Sanders S; Ek W; Harrison RF; Moayyedi P; de Caestecker J; Barr H; Stupka E; Vaughan TL; Peltonen L; Spencer CC; Tomlinson I; Donnelly P; Jankowski JA; ;
Nat Genet; 2012 Oct; 44(10):1131-6. PubMed ID: 22961001
[TBL] [Abstract][Full Text] [Related]
10. Genotypic and functional roles of IL-1B and IL-1RN on the risk of gastroesophageal reflux disease: the presence of IL-1B-511*T/IL-1RN*1 (T1) haplotype may protect against the disease.
Chourasia D; Achyut BR; Tripathi S; Mittal B; Mittal RD; Ghoshal UC
Am J Gastroenterol; 2009 Nov; 104(11):2704-13. PubMed ID: 19603010
[TBL] [Abstract][Full Text] [Related]
11. Genes of the interleukin-18 pathway are associated with susceptibility to Barrett's esophagus and esophageal adenocarcinoma.
Babar M; Ryan AW; Anderson LA; Segurado R; Turner G; Murray LJ; Murphy SJ; Johnston BT; Comber H; Reynolds JV; McManus R
Am J Gastroenterol; 2012 Sep; 107(9):1331-41. PubMed ID: 22664470
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms of microsomal epoxide hydroxylase and glutathione S-transferases M1, T1 and P1, interactions with smoking, and risk for esophageal (Barrett) adenocarcinoma.
Casson AG; Zheng Z; Porter GA; Guernsey DL
Cancer Detect Prev; 2006; 30(5):423-31. PubMed ID: 17064856
[TBL] [Abstract][Full Text] [Related]
13. The real value of lower esophageal sphincter measurement for predicting acid gastroesophageal reflux or Barrett's esophagus.
Alonso O; Hernández D; Moreno E; Manrique A; Moreno A; García-Sesma A; Calvo J
J Gastrointest Surg; 2005; 9(7):973-9. PubMed ID: 16137594
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 polymorphism (G870A) and risk for esophageal adenocarcinoma.
Casson AG; Zheng Z; Evans SC; Geldenhuys L; van Zanten SV; Veugelers PJ; Porter GA; Guernsey DL
Cancer; 2005 Aug; 104(4):730-9. PubMed ID: 15971196
[TBL] [Abstract][Full Text] [Related]
15. Is Barrett's esophagus characterized by more pronounced acid reflux than severe esophagitis?
Coenraad M; Masclee AA; Straathof JW; Ganesh S; Griffioen G; Lamers CB
Am J Gastroenterol; 1998 Jul; 93(7):1068-72. PubMed ID: 9672332
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and predictors of columnar lined esophagus in gastroesophageal reflux disease (GERD) patients undergoing upper endoscopy.
Balasubramanian G; Singh M; Gupta N; Gaddam S; Giacchino M; Wani SB; Moloney B; Higbee AD; Rastogi A; Bansal A; Sharma P
Am J Gastroenterol; 2012 Nov; 107(11):1655-61. PubMed ID: 23032983
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of surgical patients with gastroesophageal reflux disease and Barrett's esophagus].
Zsolt S; Paszt A; Géczi T; Abrahám S; Tóth I; Horváth Z; Pieler J; Tajti J; Varga A; Tiszlavicz L; Németh I; Izbéki F; Rosztóczy A; Wittmann T; Lázár G
Magy Seb; 2014 Oct; 67(5):287-96. PubMed ID: 25327403
[TBL] [Abstract][Full Text] [Related]
18. Risk factors in the development of esophageal adenocarcinoma.
Pohl H; Wrobel K; Bojarski C; Voderholzer W; Sonnenberg A; Rösch T; Baumgart DC
Am J Gastroenterol; 2013 Feb; 108(2):200-7. PubMed ID: 23247577
[TBL] [Abstract][Full Text] [Related]
19. Gastroesophageal reflux disease is associated with the C825T polymorphism in the G-protein beta3 subunit gene (GNB3).
de Vries DR; ter Linde JJ; van Herwaarden MA; Smout AJ; Samsom M
Am J Gastroenterol; 2009 Feb; 104(2):281-5. PubMed ID: 19174793
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms of glutathione S-transferase M1, T1 and P1 in patients with reflux esophagitis and Barrett's esophagus.
Kala Z; Dolina J; Marek F; Izakovicova Holla L
J Hum Genet; 2007; 52(6):527-534. PubMed ID: 17476458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
